0001562180-24-002594.txt : 20240312 0001562180-24-002594.hdr.sgml : 20240312 20240312162010 ACCESSION NUMBER: 0001562180-24-002594 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATLIN DAVID J CENTRAL INDEX KEY: 0001251956 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39834 FILM NUMBER: 24742348 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clene Inc. CENTRAL INDEX KEY: 0001822791 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 852828339 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-676-9695 MAIL ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: Chelsea Worldwide Inc. DATE OF NAME CHANGE: 20200827 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-03-11 false 0001822791 Clene Inc. CLNN 0001251956 MATLIN DAVID J 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121 true false false false false Stock Options (Right to buy) 0.44 2024-03-11 4 A false 57488.00 0.00 A 2034-03-11 Common Stock 57488.00 57488.00 D This option was granted on March 11, 2024 as an option for 57,488 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant. /s/ Jerry Miraglia POA 2024-03-12